In the article on how pomegranate extract inhibits NF-κB in the September 2008 issue (1), the authors wish to include the following policy clarification: POM Wonderful, LLC completed all animal testing on pomegranate extracts as of December 2007 and has no plans for future testing in accordance with Company policy. No funds from Pom Wonderful were used in support of the in vivo experiments as described in our manuscript.

Rettig MB, Heber D, An J, Seeram NP, Rao JY, Liu H, Klatte T, Belldegrun A, Moro A, Henning SM, Mo D, Aronson WJ, Pantuck A. Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-κB–dependent mechanism.
Mol Cancer Ther